Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zinbryta® (daclizumab) – Drug withdrawal
March 2, 2018 - Biogen and AbbVie announced the voluntary worldwide withdrawal of marketing authorizations for Zinbryta (daclizumab) due to the nature and complexity of adverse events being reported with Zinbryta use.
